Article
Leucine-Rich Repeat Kinases.
Annual review of biochemistry - 1 Aug 2024
Alessi Dario R, Pfeffer Suzanne R
Abstract excerpt
Activating mutations in leucine-rich repeat kinase 2 (LRRK2) represent the most common cause of monogenic Parkinson's disease. LRRK2 is a large multidomain protein kinase that phosphorylates a specific subset of the ∼65 human Rab GTPases, which are master regulators of the secretory and endocytic pathways. After phosphorylation by LRRK2, Rabs lose the capacity to bind cognate effector proteins and guanine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
